
S. Allyson Andrews, PharmD
Advertisement
Articles by S. Allyson Andrews, PharmD

Advertisement
Latest Updated Articles
Celecoxib: A COX-2 InhibitorPublished: April 1st 1999 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
3
EPCORE FL-1: Adding Epcoritamab to R2 Delivers “New Benchmark” in Second-Line Follicular Lymphoma
4
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
5



